Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-194032
Filing Date
2026-04-30
Accepted
2026-04-30 07:35:52
Documents
5
Period of Report
2026-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2026_pyxs-14a.htm DEF 14A 983830
2 GRAPHIC img251211442_0.jpg GRAPHIC 29935
3 GRAPHIC img251211442_1.jpg GRAPHIC 41024
4 GRAPHIC img251211442_2.jpg GRAPHIC 366359
5 GRAPHIC img251211442_3.jpg GRAPHIC 168893
  Complete submission text file 0001193125-26-194032.txt   1820362
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40881 | Film No.: 26920112
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)